BioFire’s Respiratory Panel

BioFire’s Respiratory Panel can diagnose a number of respiratory conditions at the same time. This is particularly important during the current pandemic. Some research suggests that up to 20 percent of people with COVID-19 are also infected with at least one other respiratory virus. Not treating these additional infections could slow your healing from COVID-19. Our advanced lab tests allow doctors to develop treatment plans that can address all infections you may have.

“This tool helps us improve patient care and satisfaction by providing comprehensive testing and faster, better results,” says Shelly Nortin, MT (AAB), medical technologist at Ste. Genevieve County Memorial Hospital. “From admission and treatment options to additional testing or isolation, quick turnaround helps clinicians make quick, accurate decisions.”

FAST AND SENSITIVE

BioFire’s Respiratory Panel can determine the presence of viruses and other germs more quickly and with greater sensitivity than other testing methods. Viruses, bacteria, yeast, and antimicrobial resistant genes are all detected by a single test. When symptoms make it difficult to determine which disease is causing problems, BioFire provides a precise diagnosis. At Ste. Genevieve County Memorial Hospital, BioFire’s Respiratory Panel is used to diagnose 22 different respiratory illnesses, including:
• COVID-19
• Influenza
• Respiratory syncytial virus, or RSV

We will soon have multiple tests available using the BioFire system for stool and blood pathogens.

LESS WAITING, MORE HEALING

During a BioFire respiratory test collection, a swab is wiped around your nasal cavity and then submitted to the laboratory. Results are typically available within an hour. Thanks to BioFire’s quick and accurate results, you spend less time waiting, and your provider can begin treatment earlier and with greater confidence.

 “Ste. Genevieve County Memorial Hospital works hard to bring the most technologically advanced testing to the hospital,” Shelly says. “It’s important to make this type of advance accessible, so patients don’t have to go to a large hospital setting and can stay in the community for quality care.”